Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Natera, Inc. - Common Stock (NQ:NTRA)

259.97 +25.21 (+10.74%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,941,013
Open 243.00
Bid (Size) 255.00 (100)
Ask (Size) 275.80 (100)
Prev. Close 234.76
Today's Range 239.00 - 264.65
52wk Range 131.81 - 256.36
Shares Outstanding 139,693,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Why Natera (NTRA) Stock Is Up Today
What Happened? Shares of genetic testing company Natera (NASDAQ:NTRA). jumped 7.7% in the morning session after the company announced its Signatera test rece... 
Via StockStory
Topics Artificial Intelligence
News headline image
NCCN Recommends ctDNA-MRD Testing Using Signatera™ Technology in Landmark Bladder Cancer Guideline Update
From Natera, Inc.
Via Business Wire

Performance

YTD
+13.6%
+13.6%
1 Month
+29.4%
+29.4%
3 Month
+33.6%
+33.6%
6 Month
+10.3%
+10.3%
1 Year
+52.6%
+52.6%

More News

Read More
News headline image
Natera to Showcase Organ Health Leadership with 21 Presentations at the American Transplant Congress
From Natera, Inc.
Via Business Wire
News headline image
1 Healthcare Stock for Long-Term Investors and 2 We Turn Down
Via StockStory
Natera (NTRA) Q1 Revenue Beat Overshadowed by EPS Miss and Operating Losses ↗
Via Chartmill
News headline image
1 Cash-Heavy Stock on Our Buy List and 2 We Avoid
Via StockStory
Topics Retirement
News headline image
2 Large-Cap Stocks Worth Your Attention and 1 We Turn Down
Via StockStory
News headline image
Natera and CytoDyn Announce Strategic Collaboration to Advance ctDNA-Guided Development and Molecular Response Analysis in Metastatic Colorectal Cancer
From Natera, Inc.
Via Business Wire
News headline image
Here's Billionaire Stanley Druckenmiller's Top Holding (Hint: It's Not Alphabet or Nvidia) ↗
Via The Motley Fool
News headline image
Natera Appoints Oncology Leaders Drs. Thomas Lynch and Eric Rubin to Board of Directors
From Natera, Inc.
Via Business Wire
News headline image
NWI Management Dumps 42,700 MercadoLibre Shares Worth $82.4 Million ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Natera Announces Collaboration with Diakonos Oncology for Signatera™ in Refractory Melanoma
From Natera, Inc.
Via Business Wire
News headline image
Natera Enrolls First Patients in SIGNAL-ER 101, a Prospective, Interventional Study Evaluating MRD-Guided Therapy in Breast Cancer
From Natera, Inc.
Via Business Wire
News headline image
Natera to Launch Enhanced Panorama™ NIPT, Powered by Novel SNP-Informed Deep Sequencing Technology
From Natera, Inc.
Via Business Wire
News headline image
Natera to Present 35 Studies at ASCO, Extending Clinical Data Leadership in Oncology
From Natera, Inc.
Via Business Wire
News headline image
Natera Announces Expansion in Austin, Creating What Is Believed to Be the Largest Sequencing Facility in the World
From Natera, Inc.
Via Business Wire
News headline image
EXPAND Trial of Natera’s Fetal Focus™ Single-Gene NIPT Surpasses >2,000 Patients Enrolled
From Natera, Inc.
Via Business Wire
News headline image
1 Mid-Cap Stock with Exciting Potential and 2 That Underwhelm
Via StockStory
News headline image
5 Must-Read Analyst Questions From Natera’s Q1 Earnings Call
Via StockStory
Topics Earnings
News headline image
Why Natera (NTRA) Shares Are Plunging Today
Via StockStory
Topics Artificial Intelligence Economy
News headline image
Natera Q1 Earnings Call Highlights ↗
Via MarketBeat
Topics Earnings
News headline image
NTRA Q1 Deep Dive: Robust Volume Growth and Product Expansion Shape Outlook
Via StockStory
News headline image
Natera NTRA Q1 2026 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
Natera’s (NASDAQ:NTRA) Q1 CY2026 Sales Top Estimates
Via StockStory
News headline image
Natera Reports First Quarter 2026 Financial Results
From Natera, Inc.
Via Business Wire

Frequently Asked Questions

Is Natera, Inc. - Common Stock publicly traded?
Yes, Natera, Inc. - Common Stock is publicly traded.
What exchange does Natera, Inc. - Common Stock trade on?
Natera, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Natera, Inc. - Common Stock?
The ticker symbol for Natera, Inc. - Common Stock is NTRA on the Nasdaq Stock Market
What is the current price of Natera, Inc. - Common Stock?
The current price of Natera, Inc. - Common Stock is 259.97
When was Natera, Inc. - Common Stock last traded?
The last trade of Natera, Inc. - Common Stock was at 06/24/26 04:00 PM ET
What is the market capitalization of Natera, Inc. - Common Stock?
The market capitalization of Natera, Inc. - Common Stock is 36.32B
How many shares of Natera, Inc. - Common Stock are outstanding?
Natera, Inc. - Common Stock has 36B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.